The BOPA Independent Sector Oncology Pharmacy (BISOP) Group was formed in January 2019 by Netty Cracknell. It arose because of a need for pharmacists in a similar position in the independent sector to share solutions and improve patient care. This group specifically addresses challenges not seen in the NHS. The group works closely with BOPA to ensure there is not a duplication of work but rather an enhancement of learning. The purpose of the group has been defined as ‘Cancer pharmacists working together to share and develop best practice to improve safety, patient care and clinical governance in private healthcare through a supportive network’.
Clayton Wong
Chair
Clayton Wong
Clayton works as Lead Cancer Services Pharmacist at the Royal Free London Hospital. He is a specialist cancer pharmacist with a generalist interest. Clayton has experience working in both the public and independent sectors. He is an independent prescriber, with experience of managing patients with urological cancers. Clayton cares about the holistic care of patients and improving their health outcomes.
Passionate about educational and training, Clayton is in particular keen on promoting the cancer specialties in an engaging and easy-to-understand manner, and developing others’ interests in learning about cancer. Clayton is a member of the Royal Pharmaceutical Society Mentoring Advisory Group, and he mentors pharmacists and students with the RPS and the University of Nottingham. He also works with the CPPE and Macmillan Cancer Support to review content of learning materials and patient information for pharmacy professionals, patients and carers.
Clayton believes continuous quality improvement is an essential element of professional development. He is an advocate for practice research in pharmacy, having implemented numerous service development projects within his previous NHS Trusts, which have been published as posters at the BOPA symposium over the last few years. He is currently on the Faculty of Royal College of Radiologists Clinical Oncology Exam Board as a Clinical Pharmacology Specialist Examiner. Clayton is a qualified pharmacist in two countries.
Netty Cracknell
Member and Past Chair
Netty Cracknell
Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK. She is currently Lead Cancer Pharmacist for Ramsay Health Care UK. Netty is currently President of The International Society of Oncology Pharmacy Practitioners (ISOPP) and a member of the UK SACT Board. Netty has previously held various leadership positions within the British Oncology Pharmacy Association (BOPA) and has independently led several National and International Projects. Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023.
Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media. Netty also has a keen interest in education and training and uses her strengths to support all pharmacy staff in all sectors and countries to improve access to learning globally.
Titilayo Alagbe
Member
Titilayo Alagbe
Atia Aslam
Member
Atia Aslam
Atia is an oncology pharmacist with 20 years of experience in oncology pharmacy, all of it in the independent sector. She has been a member of BISOP for a number of years, believing strongly in collaborating to share best practice, clinical and quality governance, and ultimately putting patient safety at the heart of everything we do.
Holly O'Brien
Member
Holly O'Brien
James Clark
Member
James Clark
James is a Cancer Services Pharmacist by background having spent six year at the Christie NHS Foundation Trust. He is currently working for LloydsPharmacy Clinical Homecare (LPCH) as the Head of Oncology – looking after out of hospital clinical services for all the Oncology services. James also recently worked for the Greater Manchester Cancer Vanguard – part of the National Cancer Vanguard – as the Programme Manager looking after 16 innovative projects. James is a keen advocate for showcasing clinical homecare and community pharmacy’s potential as core part of the National Health Service – which has the capability to have a positive impact on health from prevention of non-communicable disease to the management of long term chronic disease. James is also interested in optimal dosing in oncology drugs – specifically immunotherapies and the impact on service delivery.
Jared Bannister
Member
Jared Bannister
Rahil Ahmed
Member
Rahil Ahmed
Rahil Ahmed is Head of Pharmacy Cancer Services at Circle Health Group with over 18 years oncology experience in the NHS and private healthcare sector.
Rahil has worked at different NHS and private hospitals in his pharmacy career including The Christie in Manchester. Rahil moved to Independent sector in 2012 with Circle Health Group where he worked as pharmacy manager at The Alexandra hospital Cheadle, and later as the national lead pharmacist for chemotherapy and e-prescribing. In his current role he holds the position of head of pharmacy cancer services where he leads, oversees and manages all aspects of oncology pharmacy service and practice across 50+ Circle health group hospitals.
Rahil has been involved in many oncology projects and groups in his career both at his organisation and also at national level. Rahil has posters and publications at BOPA conferences and journals. Rahil is passionate about improving cancer care, treatments and improving safety for patients and practitioners through innovation and collaboration.
Lynn Ansell
Member
Lynn Ansell
Lynn is Quality Lead for Oncology Pharmacy at Nuffield Health responsible for Oncology Pharmacy Leadership within the organisation and supporting and implementing the National Cancer Strategy and championing clinical standards in the area of oncology.
As well as working in the independent sector, she has also worked in the NHS and has been involved in many projects including setting up new oncology services, implementation of oncology electronic prescribing systems, introducing new training programmes and setting up new governance structures around the introduction and monitoring of oncology medicines.
Lynn is passionate about the quality and governance around oncology services in the independent sector and feels strongly that oncology teams across the sector and the NHS should work together to ensure that all patients receive the best quality care.
Latest BOPA Independent Sector Oncology Pharmacy (BISOP) Group Downloads
Minutes
2019 Jan Mins BOPA Private Oncology Pharmacist Group (BPOP)
There are several specialist interest groups with BOPA. The groups and BOPA work together jointly to promote excellence in the pharmaceutical care of patients with cancer through education, communication, research or innovation.
There are several subcommittees & working groups that report directly to the Executive Committee each month. These subcommittees & working groups support the executive committee and keep the organisation at the forefront of care.
The Executive Committee work on behalf of the BOPA members to prioritise and co-ordinate the many activities and workstreams required to achieve our goals
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.